Omnicell Director Departs, New Director Appointed
Ticker: OMCL · Form: 8-K · Filed: Mar 12, 2025 · CIK: 926326
| Field | Detail |
|---|---|
| Company | Omnicell, Inc. (OMCL) |
| Form Type | 8-K |
| Filed Date | Mar 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation
Related Tickers: OMCL
TL;DR
Omnicell board shakeup: Johnson out, Schlotterbeck in. Officer pay details also filed.
AI Summary
Omnicell, Inc. announced on March 12, 2025, the departure of director Dr. Robert L. Johnson and the appointment of Dr. David L. Schlotterbeck as a new director. The company also disclosed compensatory arrangements for certain officers, though specific details and dollar amounts were not provided in this excerpt.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing primarily concerns routine board changes and compensatory arrangements, with no immediate financial distress or significant operational shifts indicated.
Key Players & Entities
- Omnicell, Inc. (company) — Registrant
- Dr. Robert L. Johnson (person) — Departing Director
- Dr. David L. Schlotterbeck (person) — Appointed Director
FAQ
What is the effective date of Dr. Robert L. Johnson's departure from the Omnicell board?
The filing indicates the report date is March 12, 2025, and the event pertains to the departure of directors, implying the departure occurred on or before this date.
Who has been appointed as a new director to Omnicell's board?
Dr. David L. Schlotterbeck has been appointed as a new director.
What specific compensatory arrangements for officers are mentioned in the filing?
The filing mentions 'Compensatory Arrangements of Certain Officers' as an item of disclosure, but specific details or dollar amounts are not provided in this excerpt.
Under which section of the SEC Act is this 8-K filed?
This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is Omnicell, Inc.'s state of incorporation?
Omnicell, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 12, 2025 by Dr. Robert L. Johnson regarding OMNICELL, INC. (OMCL).